Optical coherence tomography angiography features of choroidal neovascularization secondary to angioid streaks.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
03 2019
Historique:
received: 25 01 2018
accepted: 07 08 2018
revised: 25 07 2018
pubmed: 27 9 2018
medline: 23 8 2019
entrez: 26 9 2018
Statut: ppublish

Résumé

To characterize the features of choroidal neovascularization (CNV) secondary to angioid streaks (AS) with optical coherence tomography angiography (OCT-A) and to assess its sensitivity in CNV detection in this particular context. Consecutive patients, both with treatment-naïve and recurrent CNV associated with angioid streaks were prospectively analyzed. All patients underwent macular imaging by fluorescein angiography (FA), indocyanine green angiography (ICGA), spectral-domain (SD)-OCT, and OCT-A (AngioVue, Optovue, Optovue Inc., Freemont, CA, USA). OCT-A detection rate of CNV associated to AS was evaluated by two independent observers. We studied the association between OCT-A feature and either exudative or active status using Fisher exact test. A total of 32 eyes of 18 consecutive patients were included in the analysis. OCT-A was able to detect CNV associated with angioid streaks in 87.5 % (28/32) eyes. OCT-A phenotypes of CNV were classified into interlacing pattern in 9 eyes, pruned vascular tree pattern in 7 eyes, and combined pattern in 12 eyes (Interuser agreement: 0.871 ± 0.071). CNV were not detectable in 4/32 eyes. There was a statistically significant association between the presence in OCT-A of densely ramified networks with both previous treatment status in the last 6 months (p < 0.001) and with exudative signs on SD-OCT (p = 0.014). OCT-A appears as a sensitive tool for detection of CNV secondary to AS. The interlacing pattern was significantly associated with active and exudative features.

Identifiants

pubmed: 30250237
doi: 10.1038/s41433-018-0213-1
pii: 10.1038/s41433-018-0213-1
pmc: PMC6460696
doi:

Substances chimiques

Coloring Agents 0
Indocyanine Green IX6J1063HV

Types de publication

Journal Article

Langues

eng

Pagination

385-391

Références

Am J Med. 1961 Apr;30:537-43
pubmed: 13695083
Br J Ophthalmol. 2009 Feb;93(2):155-8
pubmed: 18971232
Br J Ophthalmol. 2009 Feb;93(2):182-5
pubmed: 18984656
Eur J Ophthalmol. 2009 Jan-Feb;19(1):151-3
pubmed: 19123166
Am J Ophthalmol. 2009 Oct;148(4):584-590.e2
pubmed: 19541288
Am J Ophthalmol. 2010 Nov;150(5):692-700.e1
pubmed: 20719301
Opt Express. 2012 Feb 13;20(4):4710-25
pubmed: 22418228
Ophthalmologica. 1988;197(1):36-41
pubmed: 2460816
Am J Ophthalmol. 2015 Jul;160(1):6-16
pubmed: 25887628
Am J Ophthalmol. 2015 Oct;160(4):739-48.e2
pubmed: 26164826
Ophthalmic Res. 2015;54(2):57-63
pubmed: 26201877
Retina. 2016 Mar;36(3):483-91
pubmed: 26355947
Retina. 2015 Nov;35(11):2212-8
pubmed: 26441269
Retina. 2015 Nov;35(11):2275-84
pubmed: 26457397
Retina. 2015 Nov;35(11):2236-41
pubmed: 26457399
Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7638-45
pubmed: 26624495
J Ophthalmol. 2015;2015:134783
pubmed: 26634150
J Fr Ophtalmol. 2016 Apr;39(4):370-5
pubmed: 26850508
Ophthalmic Surg Lasers Imaging Retina. 2016 Feb;47(2):128-33
pubmed: 26878445
Br J Ophthalmol. 2016 Dec;100(12):1724-1730
pubmed: 26951771
Retina. 2016 Nov;36(11):2051-2058
pubmed: 27164548
Br J Ophthalmol. 2017 May;101(5):609-615
pubmed: 27531357
Retina. 2017 Feb;37(2):222-233
pubmed: 27627752
Retina. 2017 Nov;37(11):2095-2101
pubmed: 28590317
Retina. 2018 Nov;38(11):2128-2136
pubmed: 28961674
Retina. 2019 Mar;39(3):548-557
pubmed: 29210939
Am J Ophthalmol. 1967 Mar;63(3):Suppl:1-139
pubmed: 6019308
Retina. 1981;1(2):75-83
pubmed: 6184760
Surv Ophthalmol. 1982 Mar-Apr;26(5):235-46
pubmed: 7046115
Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74
pubmed: 7604360
Am J Ophthalmol. 1993 Oct 15;116(4):414-23
pubmed: 7692728
Ophthalmology. 1996 Aug;103(8):1260-70
pubmed: 8764797
Jpn J Ophthalmol. 1998 Jul-Aug;42(4):300-3
pubmed: 9749871

Auteurs

T Chapron (T)

Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris XII, Créteil, France.

G Mimoun (G)

Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris XII, Créteil, France.
Centre Ophtalmologique d'Imagerie de l'Ecole Militaire, Paris, France.

A Miere (A)

Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris XII, Créteil, France.

M Srour (M)

Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris XII, Créteil, France.

A El Ameen (A)

Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris XII, Créteil, France.

O Semoun (O)

Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris XII, Créteil, France.

E H Souied (EH)

Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris XII, Créteil, France. eric.souied@chicreteil.fr.
University of Paris-Est-Créteil-Val-de-Marne, Créteil, France. eric.souied@chicreteil.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH